Personalized Medicine Market 2025: The Critical Role of Rare Diseases Drive Personalized Medicine Growth Driver in Industry Evolution

 

The personalized medicine market size has grown rapidly in recent years. It will grow from $386.27 billion in 2024 to $426.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%.  The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.

The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $662.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%.  The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.

Get Your Free Sample of The Global Personalized Medicine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Which industry factors have accelerated the personalized medicine market’s expansion?
The rising prevalence of rare diseases is expected to drive the growth of the personalized medicine market. This increase refers to the growing number of individuals diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine offers tailored treatment options, addressing the unique needs of patients with rare diseases. For instance, in February 2024, according to the Genetic Alliance UK, a UK-based national charity supporting people affected by genetic, rare and undiagnosed conditions, in the UK, 3.5 million people are living with a rare condition, and 1 in 17 individuals will be affected by a rare condition at some point in their lifetime. Therefore, rising prevalence of rare diseases continues to grow, it is fueling the expansion of the personalized medicine market.

What are the primary segments of the personalized medicine market?
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which firms are leading the personalized medicine market?
Major companies operating in the personalized medicine market include  Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Which market trends are set to define the future of the personalized medicine market?
Technological advancements are a key trend gaining popularity in the personalized medicine market. Major companies operating in the personalized medicine market are adopting new technologies to sustain their position in the market. For instance, in April 2023, OM1, a US-based healthcare company that utilizes real-world data and artificial intelligence (AI) to assist healthcare providers, patented an AI-powered platform to accelerate personalized medicine. This technology employs large-scale data analysis to generate meaningful insights into diagnoses, progression, and treatment responses. Its significance lies in offering tailored healthcare inputs, enhancing informed decision-making for healthcare providers, and expediting clinical trials by identifying suitable candidates efficiently, contributing to the advancement of personalized medicine in the market.

Which geographic trends are shaping the personalized medicine market, and which region has the highest market share?
The countries covered in the personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Does The Personalized Medicine Market Report 2025 Offer?
The personalized medicine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Personalized medicine is tailoring medical treatment to an individual's specific genetic, environmental, and lifestyle factors by considering an individual's unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10272

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model